Stay updated on Pembrolizumab + Imprime PGG in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Imprime PGG in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Imprime PGG in NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.2 (replacing Revision: v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T01:42:07.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision label changed from v3.4.0 to v3.4.1 on the page; no changes to study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T23:32:11.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Introduced a glossary toggle and updated metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). The older lowercase labels and previous revision tag (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4) were removed.
    Difference
    0.2%
    Check dated 2026-01-28T19:42:25.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Added new update dates (2026-01-20, 2025-12-30, 2025-12) and removed older update dates (2024-08-13, 2024-07-18, 2024-07) from the study record history. These are administrative metadata updates that do not modify the study content or outcomes.
    Difference
    0.2%
    Check dated 2026-01-21T06:27:56.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The study documents page now shows Revision: v3.3.4 and removes Revision: v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-14T04:24:51.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    A consolidated Locations section listing study sites by state (Illinois, Indiana, Iowa, New Jersey, Pennsylvania) has been added, and the per-state location blocks have been removed; the revision is updated to v3.3.3.
    Difference
    0.6%
    Check dated 2025-12-23T20:56:49.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Imprime PGG in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Imprime PGG in NSCLC Clinical Trial page.